• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

Decompressive craniectomy linked with decreased mortality in TBI: The RESCUEicp trial

byMatthew GrowdonandShaidah Deghan, MSc. MD
September 23, 2016
in Emergency, Neurology, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Patients with traumatic brain injury (TBI) and refractory intracranial hypertension following 2 stages of standard therapy who were then randomized to receive decompressive craniectomy had lower rates of mortality and higher rates of vegetative state at 6 months compared to those treated with standard medical therapy alone.

2. Adverse events occurred significantly more frequently in the surgical group, though survivors in the surgical group had significantly shortened stays in the ICU.

Evidence Rating Level: 1 (Excellent)

Study Rundown: TBI can be complicated by elevated intracranial pressure (ICP) secondary to hematomas, contusions, diffuse brain swelling, or hydrocephalus. The role of decompressive craniectomy, in which a large section of the skull is removed to relieve increased pressure and then reconstructed during a follow-up interval, remains unclear. A prior trial deploying craniectomy for patients with elevated ICP after first-tier approaches were utilized revealed more unfavorable outcomes in the craniectomy group compared to the medically treated group. In the Randomized Evaluation of Surgery with Craniectomy for Uncontrollable Elevation of Intracranial Pressure (RESCUEicp) trial, decompressive craniectomy was deployed as as last-tier intervention.

Patients with uncontrollable intracranial hypertension following two tiers of standard therapy were randomized to receive expedited craniectomy, while those in the medical group continued to receive stage 1 and 2 treatments (including basic measures, such as head elevations, ventilation, sedation, and medical therapies such as use of hypertonic solution). The authors found that patients in the craniectomy group had significantly decreased mortality at 6 and 12 months as well as increased rates of vegetative state; the outcome of an upper severe disability or better was higher in the craniectomy group. The results of this trial will help inform patients and clinicians in balancing the potential benefits of decompressive craniectomy for TBI with the risk of a vegetative state as an outcome. The results of the trial were limited by the lack of reporting of outcomes related to cranial reconstruction, which generally took place a few weeks to months after the craniectomy.

Click to read the study, published in NEJM

Relevant Reading: Decompressive craniectomy in diffuse traumatic brain injury

RELATED REPORTS

Exhaled volatile organic compounds predict bronchopulmonary dysplasia in preterm infants

Wellness Check: Mental Health

SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring

In-Depth [randomized controlled trial]: In this international, multicenter trial, 408 patients with TBI and refractory intracranial hypertension (defined as >25 mmHg) were randomized either to receive decompressive craniectomy or continued medical therapy. This intervention was offered as a last-tier, following standard medical therapies. Patients that were selected for surgery either underwent large unilateral frontotemporoparietal or bifrontal craniectomy, with the exact procedure left up to the discretion of the surgery. The primary outcome measure was the Extended Glasgow Outcome Scale (GOS-E) at 6 months following randomization. This scale scores individuals from death and vegetative state on one end of the spectrum to “upper good recovery” on the other, with 8 stages that reflect varying levels of dependent versus independent function. The primary outcome differed significantly between the groups (p < 0.001), allowing the authors to report descriptive statistics of the GOS-E outcomes: death, 26.9% in the surgical group vs 48.9% in the medical group; vegetative state, 8.5% vs 2.1%; lower severe disability (dependent on others for care), 21.9% vs 14.4%; upper severe disability (independent at home), 15.4% vs 8.0%; moderate disability, 23.4% vs 19.7%; good recovery, 4.0% vs 6.9%. Adverse events were more common in the craniectomy group (16.3% vs 9.2%, p = 0.03), though patients in the surgical group who survived had a shorter median time in the ICU.

Image: CC/Wiki

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

CPAP is superior to nasal high-flow therapy as primary support for preterm infants

Next Post

Wearable technology does not improve weight loss when added to behavioral intervention

RelatedReports

Quick Take: Analgesic efficacy and safety of morphine in the Procedural Pain in Premature Infants (Poppi) study: randomised placebo-controlled trial
Chronic Disease

Exhaled volatile organic compounds predict bronchopulmonary dysplasia in preterm infants

March 30, 2023
Quick Take: Prevalence and Treatment of Depression, Anxiety, and Conduct Problems in US Children
Wellness

Wellness Check: Mental Health

March 30, 2023
Paternal factors associated with short interpregnancy interval
Infectious Disease

SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring

March 29, 2023
No difference in PET-CT surveillance versus planned neck dissection in advanced head and neck cancer
Chronic Disease

Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma

March 29, 2023
Next Post
Inhibition of apoliprotein lowers triglyceride levels

Wearable technology does not improve weight loss when added to behavioral intervention

Eating in the absence of hunger linked to toddler obesity

Early food introduction in infant diets associated with lower risk of allergic disease

Non-TNF-targeted therapies more effective than anti-TNF agents in uncontrolled rheumatoid arthritis

Non-TNF-targeted therapies more effective than anti-TNF agents in uncontrolled rheumatoid arthritis

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Exhaled volatile organic compounds predict bronchopulmonary dysplasia in preterm infants
  • Wellness Check: Mental Health
  • SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options